Many Chest Radiographs in Children Unnecessary
Chest radiographs ordered for children, particularly for indications such as syncope or dizziness, do not alter the course of treatment.
CHICAGO - Certain indications for chest radiographs for children did not add any benefit, according to a study presented today at the annual meeting of the Radiological Society of North America (RSNA).
In an effort to guide physicians away from taking too many X-rays among children, researchers from the Mayo Clinic in Rochester, MN, performed a retrospective study to evaluate common indications for chest radiographs in the pediatric population and whether the images altered clinical management.
"Chest X-rays can be a valuable exam when ordered for the correct indications," researcher Ann Packard, MD, radiologist, Mayo Clinic, said in a release. "However, there are several indications where pediatric chest X-rays offer no benefit and likely should not be performed to decrease radiation dose and cost."
The researchers reviewed 719 previously acquired chest radiographs from 2008 to 2014 of children aged newborn to 17.
Eighty-two of the 719 exams were excluded due to congenital or other known heart disease, and other causes.
The researchers found that in approximately 88% of the remaining 637 patients, the exam did not alter clinical treatment. None of the patients who underwent X-rays for indications including syncope, spells, POTS, dizziness, or cyclical vomiting had any finding that affected treatment. Thirty-nine of the 330 non-excluded X-rays for chest pain were positive for pneumonia, bronchial inflammation, trauma, or other conditions.
"Approximately 12 percent of the chest X-rays for chest pain were positive and included respiratory symptoms such as cough, fever or trauma," Packard noted in the release. "
Can MRI-Based AI Bolster Biopsy Decision-Making in PI-RADS 3 Cases?
December 9th 2024In patients with PI-RADS 3 lesion assessments, the combination of AI and prostate-specific antigen density (PSAD) level achieved a 78 percent sensitivity and 93 percent negative predictive value for clinically significant prostate cancer (csPCa), according to research presented at the Radiological Society of North American (RSNA) conference.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
RSNA 2020: Addressing Healthcare Disparities and Access to Care
December 4th 2020Rich Heller, M.D., with Radiology Partners, and Lucy Spalluto, M.D., with Vanderbilt University School of Medicine, discuss the highlights of their RSNA 2020 session on health disparities, focusing on the underlying factors and challenges radiologists face to providing greater access to care.
New Interventional Radiology Research Shows Merits of Genicular Artery Embolization for Knee OA
December 3rd 2024In a cohort of over 160 patients with knee osteoarthritis (OA), including grade 4 in nearly half of the cases, genicular artery embolization led to an 87 percent improvement in the quality of life index, according to research presented at the recent RSNA conference.
Siemens Healthineers Debuts New Photon-Counting CT Systems at RSNA
December 2nd 2024Debuting at the Radiological Society of North American (RSNA) conference, the new photon-counting computed tomography (PPCT) scanners Naeotom Alpha.Pro and Naeotom Alpha.Prime reportedly combine rapid scan times with high-resolution precision.
